Structures by: Şafak C.
Total: 14
2,6,6-trimethyl-3-carbethoxy-4-(fluorophenyl)-5-oxo- 1,4,5,6,7,8-hexahydroquinoline
C21H24FNO3
Acta Crystallographica Section C (1998) 54, 6 879-882
a=10.9500(12)Å b=12.2333(9)Å c=7.1453(6)Å
α=90.242(7)° β=106.042(7)° γ=85.257(8)°
Benzyl 4-(3-chloro-2-fluorophenyl)-2-methyl-5-oxo-4,5,6,7-tetrahydro- 1<i>H</i>-cyclopenta[<i>b</i>]pyridine-3-carboxylate
C23H19ClFNO3
Acta Crystallographica Section C (2011) 67, 2 o80-o84
a=10.7944(2)Å b=13.5205(3)Å c=14.0573(3)Å
α=90.00° β=104.2378(13)° γ=90.00°
3-pyridylmethyl 4-[2-fluoro-3-(trifluoromethyl)phenyl]-2,6,6-trimethyl-5- oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
C26H24F4N2O3
Acta Crystallographica Section C (2011) 67, 2 o80-o84
a=11.3696(2)Å b=9.2177(2)Å c=21.9577(3)Å
α=90.00° β=92.5683(11)° γ=90.00°
C20H21ClN2O5
C20H21ClN2O5
Acta Crystallographica, Section C: Crystal Structure Communications (2004) 60, 10 o711-o713
a=14.8737(2)Å b=14.3865(2)Å c=17.6287(3)Å
α=90.00° β=90.00° γ=90.00°
(+-)-9-(2-Bromophenyl)-7,7-dimethyl-1,3,4,5,6,7,8,9-octahydrofuro[3,4- b]quinoline-1,8-dione
C19H18BrNO3
Acta Crystallographica Section C (2000) 56, 3 351-353
a=11.724(5)Å b=10.911(4)Å c=14.218(6)Å
α=90.00° β=113.11(4)° γ=90.00°
N,N-Diethyl-2,6,6-trimethyl-4-(3-nitrophenyl)-5-oxo- 1,4,5,6,7,8-hexahydroquinoline-3-carboxamide
C23H29N3O4
Acta Crystallographica Section C (2002) 58, 7 o436-o438
a=28.2157(11)Å b=28.2157(11)Å c=14.2592(4)Å
α=90° β=90° γ=120°
(+-)-methyl 4-(2,3-difluorophenyl)-2,6,6-trimethyl-5-oxo- 1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
C20H21F2NO3
Acta Crystallographica Section C (2005) 61, 12 o731-o734
a=7.2055(2)Å b=9.6702(4)Å c=12.9606(6)Å
α=93.9639(19)° β=92.624(2)° γ=107.904(2)°
(+-)-ethyl 4-(2,3-difluorophenyl)-2,6,6-trimethyl-5-oxo- 1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
C21H23F2NO3
Acta Crystallographica Section C (2005) 61, 12 o731-o734
a=7.0677(2)Å b=11.2167(4)Å c=12.1844(4)Å
α=83.6482(15)° β=86.333(2)° γ=73.2481(18)°
(RR,SS)/(RS,SR)-methyl 4-(2,4-chlorophenyl)-2,7-dimethyl- 5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate
C19H19Cl2NO3
Acta Crystallographica Section C (2006) 62, 4 o227-o230
a=11.6670(3)Å b=13.7746(4)Å c=11.8897(4)Å
α=90.00° β=105.4328(19)° γ=90.00°
(RR,SS)/(RS,SR)-methyl 4-(2,4-chlorophenyl)-2-methyl- 7-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate monohydrate
C24H21Cl2NO3,H2O
Acta Crystallographica Section C (2006) 62, 4 o227-o230
a=9.4543(5)Å b=9.7947(6)Å c=13.4460(9)Å
α=76.436(3)° β=89.268(4)° γ=69.471(3)°
Ethyl 2,7,7-trimethyl-4-(1-methyl-1<i>H</i>-indol-3-yl)-5-oxo-1,4,5,6,7,8- hexahydroquinoline-3-carboxylate
C24H28N2O3
Acta Crystallographica Section E (2013) 69, 1 o40-o41
a=17.4656(4)Å b=10.1883(2)Å c=12.3465(3)Å
α=90.00° β=106.806(2)° γ=90.00°
2,2,7,7-Tetramethyl-1,2,3,4,5,6,7,8-octahydroacridine-1,8-dione
C17H21NO2
Acta Crystallographica Section E (2013) 69, 1 o88-o89
a=9.99077(19)Å b=9.99077(19)Å c=14.5063(4)Å
α=90.00° β=90.00° γ=90.00°
9-(5-Bromo-1<i>H</i>-indol-3-yl)-1,2,3,4,5,6,7,8,9,10- decahydroacridine-1,8-dione dimethyl sulfoxide monosolvate
C21H19BrN2O2,C2H6OS
Acta Crystallographica Section E (2012) 68, 12 o3337
a=9.1544(4)Å b=18.9619(8)Å c=12.9790(5)Å
α=90.00° β=105.623(4)° γ=90.00°
Ethyl 4-(5-bromo-1<i>H</i>-indol-3-yl)-2,6,6-trimethyl-5-oxo-1,4,5,6,7,8- hexahydroquinoline-3-carboxylate
C23H25BrN2O3
Acta Crystallographica Section E (2012) 68, 12 o3404-o3405
a=14.0044(6)Å b=16.8802(5)Å c=18.8341(7)Å
α=90.00° β=105.582(4)° γ=90.00°